David Huntsman

Researcher

Related Research

Related News & Events

Research Highlight|December 14, 2023

BC team identifies drivers of aggressive childhood cancers and develops model to explore new treatments

A team of BC-based researchers verified two drivers of cancerous tumours caused by DICER1 syndrome and developed an animal model that will allow them ...

Research Highlight|June 22, 2023

Une nouvelle étude révèle qu’un acide aminé pourrait servir au traitement de certains cancers agressifs

Une étude conjointe menée sur trois ans par des scientifiques de l’Université McGill et de l’Université de Colombie-Britannique et financée en partie ...

Research Highlight|June 22, 2023

New study identifies amino acid to potentially treat aggressive cancers

The dietary supplement alanine has been found to be effective in the treatment of aggressive cancers in preclinical models, such as small cell carcino...

Research Highlight|August 31, 2020

New treatment possibilities for young women diagnosed with rare form of ovarian cancer

A recent finding by TFRI-funded researchers in BC may offer a new treatment possibility for people diagnosed with a rare and aggressive form of ovaria...

Research Highlight|January 15, 2020

Goundbreaking discovery could help block metastasis for two kinds of sarcomas, including the one that claimed Terry Fox

TFRI researchers have found that a family of drugs known as Class 1 HDAC inhibitors can block sarcoma metastasis in mice by hindering a cancer cell’s ...

TFRI News|June 05, 2018

Three top Canadian research teams receive $13 million to solve key cancer challenges

Three outstanding cancer research teams will receive nearly $13 million to continue their investigations into rare tumours, an inherited disorder (Li-...

Research Highlight|February 15, 2018

Therapeutic target EZH2 discovered for aggressive, untreatable ovarian cancer affecting young women

A Vancouver team led by TFRI-funded investigator Dr. David Huntsman has discovered an important therapeutic target for treating small cell carcinoma o...

Research Highlight|May 18, 2017

B.C. team study detects rare ovarian cancer mutation in ctDNA of patients

The finding by a B.C. team studying rare and forme fruste tumours is important in that it may help to identify women at risk of relapse for the diseas...

Research Highlight|June 14, 2016

Study by TFRI-funded team underscores importance of accurate diagnosis for rare ovarian and other cancers

Terry Fox-funded cancer researchers in BC led an international study to develop a new method to improve diagnosis of a rare sub-type of ovarian cancer...

All News & Events